to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The FDA has been sluggish in the approval of innovative medical devices. Read more on how delayed approval could endanger venture funding for medical device startups.
On Aug. 27, we are welcoming Slava Rubin, the CEO of Indiegogo, one of the most-successful and most-recognized crowdfunding platforms, to the Kauffman Foundation. We expect a full crowd for this event, but we also will be showing his presentation entitled “How to Raise $1Million in 30 Days or Less” on a live stream that can be found here.
Although the compensation structure for venture capital funds may not be ideal, it does not appear to be changing anytime soon. Read more about the pros and cons of the VC pay model.
Many would agree that surgeons are qualified to create innovative medical devices that may be superior to what is currently available. But the controversy arises when surgeons begin to profit by purchasing their own products for use in their patients.
Something extraordinary happened in Kansas City last Thursday. For the second year in a row, some of Kansas City's largest organizations participated in a reverse pitch. KCNext, the host and organizer, brought in a capacity crowd of over 200 entrepreneurs and other Global Entrepreneurship Week event participants. There were 65 events in Kansas City spread across a week and a half. But this event was different. This one was special.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Pharmaceutical companies are trying to adapt their marketing to an increasingly digital world. To get a handle on this environment, one company has appointed a digital advisory board of marketers from other industries.
Pharma reps at GSK are selling their products in a new way. The emphasis is more on communicating a drug's benefits and risks than trying to sell as much as possible. Read more about this change in approach to sales.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.